Mindfulness, Acceptance and Commitment Combined in Cognitive Behavioral Group Therapy (MAC-CBT®) for Patients With Depression
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Psychotherapy
- Sponsor
- Neuropsychiatrischen Zentrums Hamburg-Altona
- Enrollment
- 120
- Locations
- 1
- Primary Endpoint
- Depression - Patient Health Questionnaire-9
- Last Updated
- 4 years ago
Overview
Brief Summary
Randomized trial to proof the effects and efficacy of a new mindfulness and acceptance based group-treatment for depressive patients
Detailed Description
In this study, a randomized trial is conducted in which the participants are allocated to two different care services (MAC-CBT® vs. progressive muscle relaxation). Participants are patients with depression who have been made aware of the group therapy by their treating physicians or psychotherapists or who have read the advertising in waiting areas or on the investigators homepage. An extensive psychometric survey will be conducted at the start of the study in an interview session with a psychotherapist, who also judges if the participants are able to participate in a therapy group. The MAC-CBT® group receives an eight-session group therapy, in which the aspects of mindfulness, acceptance and commitment are taught in detail. The control group will receive an eight-session treatment with progressive muscle relaxation. Input and output results are determined using validated survey instruments. In addition, the investigators will check the data for moderating variables (e.g. age, gender, previous treatments...).
Investigators
Peter Tonn
Director
Neuropsychiatrischen Zentrums Hamburg-Altona
Eligibility Criteria
Inclusion Criteria
- •Depressive Disorder
Exclusion Criteria
- •Somatic disorder
- •psychotic disorder
- •personality disorder
Outcomes
Primary Outcomes
Depression - Patient Health Questionnaire-9
Time Frame: Measurement of PHQ-Data 3 months after inclusion of participant
Measurement of changes of depressive Symptoms, so called PHQ-9. There will be a measure of the total score, range from 9 to 36, pathological in sense of depression will be any score above 15. There is only one measurement scale (PHQ-9) with nine items, no other measurements or different units in the PHQ-9.
Secondary Outcomes
- Quality of Life - European Quality 5 Dimensions on 3 Levels(Measurement of QoL 3 months after inclusion of participant)
- Acceptance and Commitment - Questionnaire of Mindfulness, Acceptance and Commitment (MAC-Q)(Measurement of Mindfulness, Acceptance and Commitment 3 months after inclusion of participant)
- Anxiety - Generalized Anxiety Disorder(Measurement of Generalized Anxiety 3 months after inclusion of participant)